"The U.S. Congress shall have power to promote the progress of science and useful arts by securing, for limited times, to authors and inventors the exclusive right to their respective writings and discoveries."
"Is there something that we can do in Congress to make it easier to get to a generic label from a brand name label after a drug goes off the patent?"
"The Congressional Budget Office said that it would result in 38 fewer cures over the next 20 years."
"H.R. 3 really would completely gut the pharmaceutical innovations which we all so desperately need and we rely upon."
"We don't need to have cures that could potentially come in the market not coming to the market."
"Biopharmaceutical companies are far outspending the Federal Government for R&D for cures for various diseases."
"Democrats have chosen to discard months of bipartisan work and conduct this partisan hearing to attack companies that are working to help the American people."
"The FDA's rigorous process is a huge reason why so many Americans trust that the medications and the vaccines that come to market are safe and dependable."
"I do wish that my friends on the other side of the aisle, if they were serious about true reform and lowering prices we would be looking at something like H.R. 19 instead of pushing something like H.R..."
"We just simply cannot go down that path of eliminating any potential cure for some of these serious diseases."
"Policies that incentivize investment in pharmaceutical innovation is a good thing, and that is where we need to be focused."